16 Results for "

anti-amyloid

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "anti-amyloid" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99216
CAS No.: 1178862-65-1
Synonyms: PF-04360365; RN 1219

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Ponezumab (PF-04360365; RN 1219) is a humanized anti-amyloid(Amyloid-β) IgG2 monoclonal antibody. Ponezumab reduces levels in the central nervous system and improves the performance of mice in various learning and memory models. Ponezumab is applicable to the research of Alzheimer's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N1972
CAS No.: 37271-16-2
Sennoside C is an orally active component of the traditional Chinese medicine Sennae Folium. Sennoside C can bind to human lysozyme and inhibit its amyloid fibrosis (IC50: 186.20 μM). Sennoside C has certain purgative activity. Sennoside C can be used in the research of diarrhea and anti-amyloid related diseases .
loading...
    loading...
Cat. No.: HY-P9999
CAS No.: 2568868-35-7
Synonyms: RG6102; RO-7126209

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Trontinemab (RG6102) is a brain-penetrant, anti-amyloid, bispecific and humanizedized IgG1-κ antibody, targeting to plaques and transferrin receptor 1 (TFR1). Trontinemab binds to fibrillar as well as plaques triggering plaque clearance by engaging immune cells on Alzheimer disease (AD) brain sections. Trontinemab also shows specific affinity to cynomolgus and human TFR1 .
loading...
    loading...
Cat. No.: HY-P99105
CAS No.: 2414866-63-8
Synonyms: CAEL-101

Research Areas:  

Neurological Disease

Anselamimab (CAEL-101) is a chimeric monoclonal antibody for systemic light chain (AL) amyloidosis. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis .
loading...
    loading...
Cat. No.: HY-153430
CAS No.: 1210750-32-5
Purity:  99.70%
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Aβ/tau aggregation-IN-3 is a potent amyloid protein aggregation inhibitor with an IC50 of 0.85 μM by Aβ-Thioflavin T (Aβ-ThT) functional aggregation assay. Aβ/tau aggregation-IN-3 has anti-amyloid activity .
loading...
    loading...
Cat. No.: HY-P991046

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Donanemab (Mouse IgG2b) is a chimeric antibody composed of humanized variable regions and a mouse IgG2b backbone. Donanemab (Mouse IgG2b) is an anti-amyloid inhibitor used in Alzheimer's disease research.
loading...
    loading...
Cat. No.: HY-153417
CAS No.: 1396778-73-6
Purity:  99.03%
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Anti-amyloid agent-1 (ex1140) is a potent anti-amyloid compound and inhibits amyloid aggregation, provides a useful method for amyloidosis research .
loading...
    loading...
Cat. No.: HY-P991101

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Anti-Amyloid Beta Antibody (scFv59) is a human antibody expressed in CHO cells, targeting Amyloid-β. Anti-Amyloid Beta Antibody (scFv59) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P990332
Synonyms: CNTO 2125

Target:  

Amyloid-β

Research Areas:  

Inflammation/Immunology

Anti-Amyloid Beta Antibody (CNTO 2125) is a humanized antibody expressed in CHO cells, targeting Amyloid Beta/Aβ. Anti-Amyloid Beta Antibody (CNTO 2125) features a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-Amyloid Beta Antibody (CNTO 2125) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-169426
Target:  

Amyloid-β

Research Areas:  

Cancer

Anti-amyloid agent-2 (compound (R)-38) is an amyloidogenic immunoglobulin light chain stabilizer .
loading...
    loading...
Cat. No.: HY-P990333
Synonyms: DLX212

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Anti-Amyloid Beta Antibody (DLX212) is a CHO-expressed human antibody that targets Amyloid Beta/Aβ. Anti-Amyloid Beta Antibody (DLX212) contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.74 kDa. The isotype control for Anti-Amyloid Beta Antibody (DLX212) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P991536

Target:  

Amyloid-β

Research Areas:  

Neurological Disease

KHK6640 is a humanized anti-amyloid beta oligomer-specific antibody. KHK6640 demonstrates high potency and efficacy for cognitive improvement in several rodent Alzheimer’s models. KHK6640 can be studied in research for neurological diseases such as Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-W265961
CAS No.: 1096-84-0
Synonyms: ST1859; 1,1′-Methylenedi-2-naphthol
Target:  

Amyloid-β

Squoxin (ST1859) is an antiamyloid agent that specifically binds to Aβ1-42 and prevents the aggregation and fibril formation of Aβ. Squoxin crosses the blood-brain barrier (BBB) and has anthelmintic activity and anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-168079
GSK-3β inhibitor 21 (compound 44) is an ATP-competitive GSK-3β inhibitor (IC50=6.06 μM) with anti-amyloid aggregation and tau phosphorylation inhibitory activities. GSK-3β inhibitor 21 can be used in the study of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-122080
CAS No.: 616885-87-1
Memoquin is an anti-amyloid and anti-oxidant multi-target-directed ligand. Memoquin is an orally active inhibitor of BACE-1 and AChE with IC50 values of 108 and 1.55 nM, respectively. Memoquin is a cognitive enhancer that prevents the Aβ-induced neurotoxicity mediated by oxidative stress. Memoquin can be used for the research of Alzheimer’s disease (AD) .
loading...
    loading...
Cat. No.: HY-N1972R
CAS No.: 37271-16-2
Sennoside C (Standard) is the analytical standard of Sennoside C (HY-N1972). This product is intended for research and analytical applications. Sennoside C is an orally active component of the traditional Chinese medicine Sennae Folium. Sennoside C can bind to human lysozyme and inhibit its amyloid fibrosis (IC50: 186.20 μM). Sennoside C has certain purgative activity. Sennoside C can be used in the research of diarrhea and anti-amyloid related diseases .
loading...
    loading...
  • 1